Forskning ved Københavns Universitet - Københavns Universitet


Flavonoid intake and its association with atrial fi brillation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Nicola P. Bondonno
  • Kevin Murray
  • Catherine P. Bondonno
  • Joshua R. Lewis
  • Kevin D. Croft
  • Cecilie Kyrø
  • Gislason, Gunnar Hilmar
  • Tjønneland, Anne
  • Augustin Scalbert
  • Aedin Cassidy
  • Jonathan P. Piccini
  • Kim Overvad
  • Jonathan M. Hodgson
  • Frederik Dalgaard

Background & aims: Primary prevention of atrial fibrillation (AF) through behavioural and dietary modification is a critically important and unmet need. Flavonoids are bioactive dietary compounds with promising cardiovascular health benefits. Our aim was to investigate the association between flavonoid intake and clinically apparent AF.

Methods: Baseline data from 55 613 participants of the Danish Diet, Cancer and Health Study, without AF, recruited between 1993 and 1997, were cross-linked with Danish nationwide registries. Total flavonoid and flavonoid subclass intakes were calculated from validated food frequency questionnaires using the Phenol-Explorer database. Associations between flavonoid intake and incident AF (first-time hospitalization or outpatient visit) were examined using restricted cubic splines based on Cox proportional hazards models.

Results: During a median [IQR] follow-up of 21 [18-22] years, 7291 participants were diagnosed with AF. Total flavonoid intake was not statistically significantly associated with risk of incident AF in the whole cohort. However, compared to the lowest quintile, a total flavonoid intake of 1000 mg/day was associated with a lower risk of AF in smokers [0.86 (0.77, 0.96)] but not in non-smokers [0.96 (0.88, 1.06)], and a lower risk of AF in high alcohol consumers [>20 g/d: 0.84 (0.75, 0.95)] but not in low-to-moderate alcohol consumers [

Conclusion: Intake of flavonoids was not significantly associated with a lower risk of incident AF. However, higher intakes of flavonoids may be beneficial for those at a higher risk of developing AF. (C) 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

TidsskriftClinical Nutrition
Udgave nummer12
Sider (fra-til)3821-3828
Antal sider8
StatusUdgivet - 2020

ID: 254770614